GSK23336805
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK23336805, covering 2016-01-11 to 2016-01-11. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Effectiveness of a 12-Week Combination Therapy of TMC647055 and TMC435 With and Without GSK23336805 With a Pharmacokinetic Enhancer With and Without Ribavirin in Patients Infected With Chronic Genotype 1 Hepatitis C Virus [Phase 2]